Burden of multiple myeloma in China: an analysis of the Global Burden of Disease, Injuries, and Risk Factors Study 2019
Jiangmei LIU; Weiping LIU; Lan MI; Cai CAI; Tiejun GONG; Jun MA; Lijun WANG.
Chinese Medical Journal
; (24): 2834-2838, 2023.
Artículo en Inglés | WPRIM | ID: wpr-1007559
Documentos relacionados
Burden of multiple myeloma in China: an analysis of the Global Burden of Disease, Injuries, and Risk Factors Study 2019.
Burden of Parkinson Disease in China, 1990-2019: Findings from the 2019 Global Burden of Disease Study.
Changes in tuberculosis burden and its associated risk factors in Guizhou Province of China during 2006-2020: an observational study.
Benign prostatic hyperplasia burden comparison between China and United States based on the Global Burden of Disease Study 2019.
Burden of liver complications related to non-alcoholic fatty liver disease in China from 2005 to 2019: Observations from the Global Burden of Disease Study, 2019.
Incidence, prevalence and disability of spinal cord injury in China from 1990 to 2019: a systematic analysis of the Global Burden of Disease Study 2019.
[The disease burden of degenerative mitral valve disease in the Chinese population from 1990 to 2019].
Analysis of the epidemiological burden of age-related macular degeneration in China based on the data of global burden of disease.
A comparative study of the disease burden attributable to asbestos in Brazil, China, Kazakhstan, and Russia between 1990 and 2019.
Burden of viral hepatitis caused by specific aetiologies in China, 1990-2016: findings from the GBD 2016.